Like many parents, AJ & Emily Eyth were worried about their daughters’ risk to develop type 1 diabetes because AJ lives with the disease. They learned about the TrialNet Pathway to Prevention risk screening offered at the University of South Florida and decided to enroll their daughters, Kacie & Kaley.

Bridget Montgomery’s introduction to type 1 diabetes was when her son, Clifford, was diagnosed in DKA at the age of 6. It was at their initial type 1 diabetes training through Children’s Hospital of Pittsburgh that she learned about the opportunity to participate in TrialNet.

Elliot, a 17-year-old from a small village outside Bristol, recently completed treatment in the Abatacept Prevention Study. He is the first person in the United Kingdom (UK) to do so.